Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease

Frontiers in Pharmacology

Volumn 5 APR, Issue , 2014, Pages

  Nisticò, Robert ^a,b   Ferraina, Caterina ^c   Marconi, Veronica ^b   Blandini, Fabio ^d   Negri, Lucia ^b   Egebjerg, Jan ^e   Feligioni, Marco ^c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e H LUNDBECK A S   (Denmark)

Author keywords

Alzheimer's disease; Neurodegeneration; SENP1; SUMO 1; SUMO 2 3; Sumoylation; Tg2576; Ubc9

Indexed keywords

BRAIN PROTEIN; MESSENGER RNA; PROTEIN SENP1; PROTEIN UBC9; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

AGE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONJUGATION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; SUMO 1 GENE; SUMOYLATION; UPREGULATION;

EID: 84901007305     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00063     Document Type: Article

References (42)

1. Balducci, C., Mehdawy, B., Mare, L., Giuliani, A., Lorenzini, L., Sivilia, S., et al. (2011). The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice. J. Alzheimer's Dis. 24, 799-816. doi: 10.3233/JAD-2011-101839
2. Bossis, G., and Melchior, F. (2006). Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell 21, 349-357. doi: 10.1016/j.molcel.2005.12.019
3. Brecht, S., Kirchhof, R., Chromik, A., Willesen, M., Nicolaus, T., Raivich, G., et al. (2005). Specific pathophysiological functions of JNK isoforms in the brain. Eur. J. Neurosci. 21, 363-377. doi: 10.1111/j.1460-9568.2005.03857.x
4. Cimarosti, H., Ashikaga, E., Jaafari, N., Dearden, L., Rubin, P., Wilkinson, K. A., et al. (2012). Enhanced SUMOylation and SENP-1 protein levels following oxygen and glucose deprivation in neurones. J. Cereb. Blood Flow Metab. 32, 17-22. doi: 10.1038/jcbfm.2011.146
5. D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., et al. (2011). Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat. Neurosci. 14, 69-76. doi: 10.1038/nn.2709
6. Deacon, R. M. J., Cholerton, L. L., Talbot, K., Nair-Roberts, R. G., Sanderson, D. J., Romberg, C., et al. (2008). Age-dependent and -independent behavioral deficits in Tg2576 mice. Behav. Brain Res. 189, 126-138. doi: 10.1016/j.bbr.2007.12.024
7. Di Domenico, F., Coccia, R., Butterfield, D. A., and Perluigi, M. (2011). Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits. Biochim. Biophys. Acta 1814, 1785-1795. doi: 10.1016/j.bbapap.2011.10.001
8. Dorval, V., and Fraser, P. E. (2006). Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J. Biol. Chem. 281, 9919-9924. doi: 10.1074/jbc. M510127200
9. Dorval, V., and Fraser, P. E. (2007). SUMO on the road to neurodegeneration. Biochim. Biophys. Acta 1773, 694-706. doi: 10.1016/j.bbamcr.2007.03.017
10. Droescher, M., Chaugule, V. K., and Pichler, A. (2013). SUMO rules: regulatory concepts and their implication in neurologic functions. Neuromolecular Med. 15, 639-660. doi: 10.1007/s12017-013-8258-6
11. Feligioni, M., Brambilla, E., Camassa, A., Sclip, A., Arnaboldi, A., Morelli, F., et al. (2011). Crosstalk between JNK and SUMO signaling pathways: deSUMOylation is protective against H(2)O(2)-induced cell injury. PLoS ONE 6:e28185. doi: 10.1371/journal.pone.0028185
12. Feligioni, M., Nishimune, A., and Henley, J. M. (2009). Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals. Eur. J. Neurosci. 29, 1348-1356. doi: 10.1111/j.1460-9568.2009.06692.x
13. Feligioni, M., and Nisticò, R. (2013). SUMO: a (Oxidative) stressed protein. Neuromolecular Med. 15, 707-719. doi: 10.1007/s12017-013-8266-6
14. Georgopoulou, N., McLaughlin, M., McFarlane, I., and Breen, K. C. (2001). The role of post-translational modification in beta-amyloid precursor protein processing. Biochem. Soc. Symp. 23-36.
15. Heun, R., Schoepf, D., Potluri, R., and Natalwala, A. (2013). Alzheimer's disease and co-morbidity: increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up. Eur. Psychiatry? 28, 40-48. doi: 10.1016/j.eurpsy.2011.06.001
16. Holman, D., Feligioni, M., and Henley, J. M. (2007). Differential redistribution of native AMPA receptor complexes following LTD induction in acute hippocampal slices. Neuropharmacology 52, 92-99. doi: 10.1016/j.neuropharm.2006.05.022
17. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., et al. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. doi: 10.1126/science.274.5284.99
18. Irizarry, M. C., McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B. T. (1997). APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965-973. doi: 10.1097/00005072-199709000-00002
19. Izco, M., Martínez, P., Corrales, A., Fandos, N., García, S., Insua, D., et al. (2014). Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Neuroscience 263C, 269-279. doi: 10.1016/j.neuroscience.2014.01.003
20. Jaafari, N., Konopacki, F. A., Owen, T. F., Kantamneni, S., Rubin, P., Craig, T. J., et al. (2013). SUMOylation is required for glycine-induced increases in AMPA receptor surface expression (ChemLTP) in hippocampal neurons. PLoS ONE 8:e52345. doi: 10.1371/journal.pone.0052345
21. Jacobsen, J. S., Wu, C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., et al. (2006). Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 5161-5166. doi: 10.1073/pnas.0600948103
22. Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., and Younkin, S. G. (2001). Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21, 372-381.
23. Klingner, M., Apelt, J., Kumar, A., Sorger, D., Sabri, O., Steinbach, J., et al. (2003). Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology. Int. J. Dev. Neurosci. 21, 357-369. doi: 10.1016/j.ijdevneu.2003.08.001
24. Krumova, P., Meulmeester, E., Garrido, M., Tirard, M., Hsiao, H.-H., Bossis, G., et al. (2011). Sumoylation inhibits alpha-synuclein aggregation and toxicity. J. Cell Biol. 194, 49-60. doi: 10.1083/jcb.201010117
25. Lee, L., Sakurai, M., Matsuzaki, S., Arancio, O., and Fraser, P. (2013). SUMO and Alzheimer's disease. Neuromolecular Med. 15, 720-736. doi: 10.1007/s12017-013-8257-7
26. Leitao, B. B., Jones, M. C., and Brosens, J. J. (2011). The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death. FASEB J. 25, 3416-3425. doi: 10.1096/fj.11-186346
27. Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., et al. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357. doi: 10.1038/nature04533
28. Li, Y., Wang, H., Wang, S., Quon, D., Liu, Y.-W., and Cordell, B. (2003). Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc. Natl. Acad. Sci. U.S.A. 100, 259-264. doi: 10.1073/pnas.0235361100
29. Marcus, J. N., and Schachter, J. (2011). Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease. J. Neurogenet. 25, 127-133. doi: 10.3109/01677063.2011.626471
30. Markesbery, W. R. (1997). Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147. doi: 10.1016/S0891-5849(96)00629-6
31. Martin, S., Nishimune, A., Mellor, J. R., and Henley, J. M. (2007). SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447, 321-325. doi: 10.1038/nature05736
32. McMillan, L. E., Brown, J. T., Henley, J. M., and Cimarosti, H. (2011). Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model. Neurosci. Lett. 502, 201-208. doi: 10.1016/j.neulet.2011.07.045
33. Moschos, S. J., Jukic, D. M., Athanassiou, C., Bhargava, R., Dacic, S., Wang, X., et al. (2010). Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Hum. Pathol. 41, 1286-1298. doi: 10.1016/j.humpath.2010.02.007
34. Pittaluga, A., Feligioni, M., Longordo, F., Luccini, E., and Raiteri, M. (2006). Trafficking of presynaptic AMPA receptors mediating neurotransmitter release: neuronal selectivity and relationships with sensitivity to cyclothiazide. Neuropharmacology 50, 286-296. doi: 10.1016/j.neuropharm.2005.09.004
35. Pittaluga, A., Segantini, D., Feligioni, M., and Raiteri, M. (2005). Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release. Br. J. Pharmacol. 144, 293-299. doi: 10.1038/sj.bjp.0705960
36. Sclip, A., Antoniou, X., Colombo, A., Camici, G. G., Pozzi, L., Cardinetti, D., et al. (2011). c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model. J. Biol. Chem. 286, 43871-43880. doi: 10.1074/jbc. M111.297515
37. Sclip, A., Arnaboldi, A., Colombo, I., Veglianese, P., Colombo, L., Messa, M., et al. (2013). Soluble Aβ oligomer-induced synaptopathy: c-Jun N-terminal kinase's role. J. Mol. Cell Biol. 5, 277-279. doi: 10.1093/jmcb/mjt015
38. Steffan, J. S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L. C., Slepko, N., et al. (2004). SUMO modification of huntingtin and huntington's disease pathology. Science 304, 100-104. doi: 10.1126/science.1092194
39. Tiraboschi, P., Hansen, L. A., Thal, L. J., and Corey-Bloom, J. (2004). The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62, 1984-1989. doi: 10.1212/01.WNL.0000129697.01779.0A
40. Tosun, D., Schuff, N., Mathis, C. A., Jagust, W., and Weiner, M. W. (2011). Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain 134, 1077-1088. doi: 10.1093/brain/awr044
41. Yun, S.-M., Cho, S.-J., Song, J. C., Song, S. Y., Jo, S. A., Jo, C., et al. (2013). SUMO1 modulates Aβ generation via BACE1 accumulation. Neurobiol. Aging 34, 650-662. doi: 10.1016/j.neurobiolaging.2012.08.005
42. Zhang, Y.-Q., and Sarge, K. D. (2008). Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels. Biochem. Biophys. Res. Commun. 374, 673-678. doi: 10.1016/j.bbrc.2008.07.109